pd 135158 has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GuimarĂ£es, FS; Netto, CF | 1 |
Akiyoshi, J; Hikichi, T; Isogawa, K; Kouno, Y; Nagayama, H; Tsutsumi, T | 1 |
2 other study(ies) available for pd 135158 and Disease Models, Animal
Article | Year |
---|---|
Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Hormone Antagonists; Immunohistochemistry; Indoles; Male; Maze Learning; Meglumine; Microinjections; Neurons; Periaqueductal Gray; Proglumide; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Sincalide; Superior Colliculi; Time Factors | 2004 |
[Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].
Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Disease Models, Animal; Indoles; Male; Meglumine; Panic Disorder; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1998 |